The Tate Chronicles: Greg Archambeau, President of Revalesio Corporation

from Healthcare NOW Radio · host Healthcare NOW Radio

On this episode Jim welcomes Greg Archambeau, President of Revalesio Corporation who discusses RNS60, a novel treatment for both ALS and acute ischemic stroke. Phase 3 trials are beginning soon based on promising Phase 2 results. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Episode metadata supplied by the publisher feed · Published Jun 13, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

The Tate Chronicles: Greg Archambeau, President of Revalesio Corporation

0:00 27:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Healthcare NOW Radio?

This episode is 27 minutes long.

When was this Healthcare NOW Radio episode published?

This episode was published on June 13, 2026.

Can I download this Healthcare NOW Radio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!